Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
09/14/1995 | CA2182103A1 9-deoxotaxane compounds |
09/14/1995 | CA2181354A1 Benzothiophene, benzofuran and indole-thiazepinones, oxazepinones and diazepinones as inhibitors of cell adhesion and as inhibitors of hiv |
09/14/1995 | CA2179287A1 In situ dissolution of alginate coatings of biological tissue transplants |
09/14/1995 | CA2166324A1 Use of compounds which inhibit phosphatidic acid formation for the manufacture of a medicament for the treatment of cancer |
09/13/1995 | EP0671468A1 Lactic acid bacteria of the genus lactobacillus |
09/13/1995 | EP0671414A1 Antithrombotic |
09/13/1995 | EP0671410A1 Antiviral compounds |
09/13/1995 | EP0671409A2 Malonic acid derivatives having anti-adhesive properties |
09/13/1995 | EP0671408A2 Carbohydrate mimetics having anti-adhesive properties |
09/13/1995 | EP0671407A2 Sulfated alpha-glycolipid derivatives as cell adhesion inhibitors |
09/13/1995 | EP0671406A2 Sulfated beta-glycolipid derivatives as cell adhesion inhibitors |
09/13/1995 | EP0671401A1 Beta lactames |
09/13/1995 | EP0671399A1 6,7-Epoxy paclitaxels |
09/13/1995 | EP0671397A1 Alkylaminoindanes compounds, processes for their preparation and pharmaceutical compositions containing them |
09/13/1995 | EP0671392A1 Substituted propane derivatives, process for their preparation and use of the compounds for the treatment of illnesses |
09/13/1995 | EP0671391A1 5-Vinyl- and 5-ethinyl-quinolinone- and -naphthyridone-carboxylic acids |
09/13/1995 | EP0671388A1 (Pyrrolidinyl)phenyl carbamates and intermediate compounds, processes for their preparation and their use as medicaments |
09/13/1995 | EP0671387A1 Fluorinated vitamin D3 derivative |
09/13/1995 | EP0671175A2 Sustained release compositions for treating periodontal disease |
09/13/1995 | EP0671173A1 Use of a tricyclic derivative for producing a medicament for the treatment of cognitive and memory disorders |
09/13/1995 | EP0671172A1 Amino acid derivative |
09/13/1995 | EP0671171A1 Use of HMG COA reductase inhibitor for the manufacture of a medicament for proventing or reducing risks of onset of cardiovascular events |
09/13/1995 | EP0671170A1 Use of pravastatin for slowing progression coronary artery atherosclerosis |
09/13/1995 | EP0671166A2 Nutrient-supplying preparation |
09/13/1995 | EP0671164A1 Skin whitening and/or anti aging composition and uses thereof |
09/13/1995 | EP0671162A2 Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use |
09/13/1995 | EP0671161A1 Ectoine and ectoine derivatives as moisturizing agents in cosmetic preparation |
09/13/1995 | EP0671160A1 Use of sulphonic acids as antiageing agents in cosmetic and/or dermatological compositions |
09/13/1995 | EP0671156A1 Cosmetic or pharmaceutical compositions containing liposomes |
09/13/1995 | EP0671005A1 Rxr homodimer formation and bridged bicyclic aromatic compounds and their use in modulating gene expression |
09/13/1995 | EP0671004A1 Allergen/inflammatory testing and diagnosis |
09/13/1995 | EP0670899A1 Heat shock proteins and the treatment of tumours |
09/13/1995 | EP0670897A1 ANTISENSE OLIGONUCLEOTIDE INHIBITION OF THE ras GENE |
09/13/1995 | EP0670839A1 Process for the preparation of 9-amino camptothecin |
09/13/1995 | EP0670838A1 SUBSTITUTED-PHENYL(N,N'-CYCLOALKYL/ALKYL CARBOXAMIDE)-1H/3H-IMIDAZO 4,5-b]PYRIDINE COMPOUNDS AS PAF ANTAGONISTS |
09/13/1995 | EP0670837A1 METHOD OF PREPARING -g(b)-CARBOLINES. |
09/13/1995 | EP0670833A1 Nitroxy compounds with pharmaceutical properties |
09/13/1995 | EP0670826A1 Fatty acid derivatives and pharmaceutical compositions containing them |
09/13/1995 | EP0670733A1 Compositions containing growth factors and antiplastic agents |
09/13/1995 | EP0670732A1 Compositions containing growth factors and antimetabolites |
09/13/1995 | EP0670725A1 Pharmaceutical compositions for use in gastrointestinal washes |
09/13/1995 | EP0670724A1 Use of mycophenolic acid, mycophenolate mofetil or derivate thereof to inhibit stenosis |
09/13/1995 | EP0670723A1 Use of thioureleylenes and thiabendazole in autoimmune diseases |
09/13/1995 | EP0670722A1 Cimetidine granules coated with a partially hydrogenated vegetable oil |
09/13/1995 | EP0670721A1 Drug for treatment and prophylaxis of bone and joint diseases |
09/13/1995 | EP0670720A1 Enzyme inhibitors |
09/13/1995 | EP0670719A1 Combination of atovaquone with proguanil for the treatment of protozoal infections |
09/13/1995 | EP0670714A1 Retinoic acid-containing compositions |
09/13/1995 | EP0670713A1 A pharmaceutical formulation |
09/13/1995 | EP0661979A4 Cross-linking oligonucleotides for enzyme-mediated triple strand formation. |
09/13/1995 | EP0615440B1 Medicament containing a 2-arylpropionic acid derivate as a nanosol and its preparation |
09/13/1995 | EP0563094B1 Pharmaceutical compositions |
09/13/1995 | EP0541706B1 Process and intermediate for the preparation of 2-hydroxy-3-sulfido-3-phenyl propanoic acids |
09/13/1995 | EP0541593B1 Cyclopentane derivatives, process for producing them and their pharmaceutical use |
09/13/1995 | EP0529002A4 Fluorescent porphyrin, and fluorescent phthalocyanine - polyethylene glycol, polyol, and saccharide derivatives as fluorescent probes |
09/13/1995 | EP0525167B1 Sustained drug release through topical application of bioadhesive liposomes |
09/13/1995 | EP0517797B1 Use of vitamin-d analogues in the treatment of acne |
09/13/1995 | EP0513068B1 Three new non-polyglutamatable deazaaminopterins and process for preparing the same |
09/13/1995 | EP0449940B1 New therapeutically active compound and a process for its preparation |
09/13/1995 | EP0429627B1 Derivatives of quinoline-3-carboxanilide |
09/13/1995 | EP0383770B1 Inhibition of eucaryotic pathogens and neoplasms with lytic peptides |
09/13/1995 | CN1108456A Benzothiazole compound, process for producing the same, and use thereof |
09/13/1995 | CN1108259A New derivatives of erythromycin, their preparation process and their use as medicaments |
09/13/1995 | CN1108257A Heterocyclically substituted phenyl-cyclohexane-carboxylic acid derivatives |
09/13/1995 | CN1108255A Methods of inhibiting the symtoms of premenstrual syndrome/late luteal phase dysphoric disorder |
09/13/1995 | CN1108254A Process for the preparation of alpha-tocopherol derivatives |
09/13/1995 | CN1108248A Glycoprotein IIB/IIIA antagonists |
09/13/1995 | CN1108247A Compounds |
09/13/1995 | CN1108245A Vitamin D3 analogs |
09/13/1995 | CN1108244A Lactone compound and process of production thereof |
09/13/1995 | CN1108240A Excitatory amino acid receptor antagonists |
09/13/1995 | CN1108104A Pharmaceutical moenomycin and derivative of same medicament containing moenomycin or derivative of same |
09/13/1995 | CN1108103A Methods of inhibiting turner's syndrome |
09/13/1995 | CN1108102A Methods of inhibiting autoimmune diseases |
09/13/1995 | CN1108101A Methods of inhibiting male infertility |
09/13/1995 | CN1108100A Methods of inhibiting breast disorders |
09/13/1995 | CN1108099A Methods of inhibiting sexual precocity |
09/13/1995 | CN1108098A Methods of inhibiting alzheimer's disease |
09/13/1995 | CN1108097A Methods of inhibiting atrophy of the skin and vagina |
09/13/1995 | CN1108096A Non-peptide tachykinin receptor antagonists |
09/13/1995 | CN1108095A Composition for prophylaxis and treatment of myopia |
09/13/1995 | CN1108094A Methods for treating resistant neoplasms |
09/13/1995 | CN1108093A Methods for inhibiting vasomotor symptons and attending psychological disturbances surrounding post-menopausal syndrome |
09/13/1995 | CN1108092A Methods of increasing macrophage function |
09/13/1995 | CN1108091A Methods of inhibiting fertility in women |
09/13/1995 | CN1108090A Methods for inhibiting LDL oxidation and atherosclerosis |
09/13/1995 | CN1029738C O-methyl derivatives of azithromycin, process and intermediate for their preparation, and use thereof in preparation of pharmaceuticals |
09/13/1995 | CN1029737C Process for preparing aminoalkylketones derivatives and use in therapy |
09/13/1995 | CN1029728C Medical liquid for treating acne |
09/13/1995 | CN1029727C Gargling toothpaste needing no brushing |
09/12/1995 | US5449840 Viricides |
09/12/1995 | US5449814 Dehydration; Michael condensation |
09/12/1995 | US5449813 Phenylethanolamino- and phenylethanolaminomethyl-tetralines, process for the preparation thereof, intermediates in said process and pharmaceutical compositions containing them |
09/12/1995 | US5449798 Phospholipid derivatives containing higher elements of the fifth group |
09/12/1995 | US5449794 Benzopyran phenol derivatives for use as antibacterial agents |
09/12/1995 | US5449787 N,N'-disubstituted amide derivatives |
09/12/1995 | US5449782 Orally active antiviral compounds |
09/12/1995 | US5449773 Antitumor agents |
09/12/1995 | US5449755 Human cyclin E |
09/12/1995 | US5449720 Amplification of the VB12 uptake system using polymers |